Fanqi Bai

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Pearlie K. Epling‐Burnette, Fanqi Bai, Jeffrey S. Painter et al. · Blood · 2007 · 219 citations · Full text

Cooperative Regulation of Mcl-1 by Janus Kinase/STAT and Phosphatidylinositol 3-Kinase Contribute to Granulocyte-Macrophage Colony-Stimulating Factor-Delayed Apoptosis in Human Neutrophils

Pearlie K. Epling‐Burnette, Bin Zhong, Fanqi Bai et al. · The Journal of Immunology · 2001 · 179 citations

A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma

Deepa Kolaseri Krishnadas, Suzanne Shusterman, Fanqi Bai et al. · Cancer Immunology Immunotherapy · 2015 · 170 citations · Full text

Immunology, Vaccine Trial, Therapeutic Vaccine +7

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome

Pearlie K. Epling‐Burnette, Jeffrey S. Painter, Dana E. Rollison et al. · Leukemia · 2007 · 128 citations

Hematological Malignancy, Myelodysplastic Syndrome, Bone Marrow Failure +10

Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells

Mei Huang, Jay F. Dorsey, PK Epling-Burnette et al. · Oncogene · 2002 · 120 citations · Full text

Signal Transduction, Signaling Pathway, Cell Regulation +9